Zobrazeno 1 - 10
of 1 434
pro vyhledávání: '"R., Saleh"'
Autor:
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, Lori Wood, Georg A. Bjarnason, Bimal Bhindi, Daniel Yick Chin Heng, Vincent Castonguay, Frederic Pouliot, Christian K. Kollmannsberger, Dominick Bosse, Naveen S. Basappa, Antonio Finelli, Nazanin Fallah-rad, Rodney H. Breau, Aly-Khan A. Lalani, Simon Tanguay, Jeffrey Graham, Ramy R. Saleh
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4704-4712 (2024)
Immunotherapy-based systemic treatment (ST) is the standard of care for most patients diagnosed with metastatic renal cell carcinoma (mRCC). Cytoreductive nephrectomy (CN) has historically shown benefit for select patients with mRCC, but its role and
Externí odkaz:
https://doaj.org/article/a3dcd2b35cca4280bfb0bb15774ac56f
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
The services provided to persons with autism spectrum disorder (ASD) and their families are considered the basic factors that help families meet their needs and those of their children. These services help persons with ASD attain an appropriate level
Externí odkaz:
https://doaj.org/article/7eef8c34b8d141999cd69492cef0166d
Autor:
Michelle B. Nadler, Brooke E. Wilson, Alexandra Desnoyers, Consolacion Molto Valiente, Ramy R. Saleh, Eitan Amir
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Approval of drugs is based on randomized trials observing statistically significant superiority of an experimental agent over a standard. Statistical significance results from a combination of effect size and sampling, with larger effect siz
Externí odkaz:
https://doaj.org/article/ad2621f4f2e041a0828784637ed92982
Autor:
Feras A. Moria, Changsu L. Park, Bernhard J. Eigl, Robyn Macfarlane, Michel Pavic, Ramy R. Saleh
Publikováno v:
Current Oncology, Vol 31, Iss 2, Pp 704-722 (2024)
Locally advanced or metastatic urothelial carcinoma (aUC) presents a significant challenge with high mortality rates. Platinum-based chemotherapy remains the established frontline standard of care, and a switch-maintenance strategy with immunotherapy
Externí odkaz:
https://doaj.org/article/3f304287e7bd48d488811d2078269278
Autor:
Simon Hwang, MD, Javier Ardebol, MD, Kassem Ghayyad, MD, Theresa Pak, DO, Joao A. Bonadiman, MD, Patrick J. Denard, MD, Mariano E. Menendez, MD, Michael H. Amini, MD, Anup Shah, MD, Andy Hartman, MD, Anthony Wei, MD, Brian Lee, MD, Benjamin W. Sears, MD, Christopher Sheu, MD, Christopher R. Lehman, MD, Daniel J. Solomon, MD, David Weinstein, MD, Dawson S. Brown, MD, David Savin, MD, Dave Huberty, MD, Dan Guttmann, MD, Dave Shukla, MD, Edward Choung, MD, Evan Lederman, MD, Elizabeth Watson, MD, Erica M. Burns, MD, Geoffrey Abrams, MD, Gregory D. Gramstad, MD, Samuel Harmsen, MD, Hafiz Kassam, MD, Jae You, MD, Jason Kurian, MD, Jason R. Saleh, MD, Jonah Davies, MD, Joseph W. Galvin, DO, Raffy Mirzayan, MD, Liang Zhou, MD, Matthew Budge, MD, Michael A. Stone, MD, Matthew Nugent, MD, Matthew Pifer, MD, Ron Navarro, MD, Niloofar Dehghan, MD, Nathan Orvets, MD, Reza Omid, MD, Robert Orfaly, MD, Peter Chalmers, MD, Peters T. Otlans, MD, MPH, Rachel M. Frank, MD, Rudolf G. Hoellrich, MD, Scott Humphrey, MD, Scott Crow, MD, Shanjean Lee, MD, Richard Lee Stowell, MD, Ekaterina Urch, MD, William Paterson, MD, John Costouros, MD, Angela Passanise, DO, Anita G. Rao, MD, Armodios Hatzidakis, MD, J Brad Butler, MD, Cay Mierisch, MD, Sara Jurek, MD, Hilary Malcarney, MD, Jason Hsu, MD, Jeffrey Tuman, MD, Jonathan Cheah, MD, John Matthews, MD, Kyong Min, MD, Lauren Hansen, MD, Julia Lee, MD, Raymond Klug, MD, Rafael Buerba, MD, MHS, Timothy Crall, MD, Todd Kim, MD, Yassamin Hazrati, MD
Publikováno v:
JSES International, Vol 7, Iss 6, Pp 2528-2533 (2023)
Background: Surgeon visual estimation of shoulder range of motion (ROM) is commonplace in the outpatient office setting and routinely reported in clinical research, but the reliability and accuracy of this practice remain unclear. The purpose of this
Externí odkaz:
https://doaj.org/article/005c274dd60c4ce39e22a9a5059bc016
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1080-1086 (2023)
Patients presenting with multiple primary malignancies remain a growing challenge for physicians due to a lack of data for generalizable guidelines. Identification of driver mutations in carcinogenesis leads to the development of targeted treatment o
Externí odkaz:
https://doaj.org/article/ba493f1a75d648719a84217842d8177d
Autor:
Alberto Hernando-Calvo, Paul Nguyen, Philippe L. Bedard, Kelvin K.W. Chan, Ramy R. Saleh, Deirdre Weymann, Celeste Yu, Eitan Amir, Dean A. Regier, Bishal Gyawali, Danielle Kain, Brooke Wilson, Craig C. Earle, Nicole Mittmann, Albiruni R. Abdul Razak, Wanrudee Isaranuwatchai, Peter Sabatini, Anna Spreafico, Tracy L. Stockley, Trevor J. Pugh, Christine Williams, Lillian L. Siu, Timothy P. Hanna
Publikováno v:
EClinicalMedicine, Vol 69, Iss , Pp 102443- (2024)
Summary: Background: To date, economic analyses of tissue-based next generation sequencing genomic profiling (NGS) for advanced solid tumors have typically required models with assumptions, with little real-world evidence on overall survival (OS), cl
Externí odkaz:
https://doaj.org/article/19ab2f66fed24a75a727e76111c21e84
Publikováno v:
FOSTER, Vol 4, Iss 1 (2023)
The focus of research on students' anxiety when speaking a foreign language, such as English, has shifted to language learning and education. However, the experience of students who reached the intermediate level remains underexplored, particularly i
Externí odkaz:
https://doaj.org/article/d2ed2f74e7b74c8dbdd6cd75aca0b3b1
Autor:
M. Abou-Hamdan, R. Saleh, S. Mani, P. Dournaud, M. Metifiot, M. L. Blondot, M. L. Andreola, F. Abdel-sater, M. De Reggi, P. Gressens, M. Laforge
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract SARS-CoV-2 interacts with cellular cholesterol during many stages of its replication cycle. Pantethine was reported to reduce total cholesterol levels and fatty acid synthesis and potentially alter different processes that might be involved
Externí odkaz:
https://doaj.org/article/02ffae40a9ef41ee935e937b166def8f
Publikováno v:
Current Oncology, Vol 29, Iss 11, Pp 8626-8637 (2022)
Background: The introduction of novel hormonal agents (NHAs) such as abiraterone acetate (ABI) and enzalutamide (ENZ) for metastatic castration-resistant prostate cancer (mCRPC) was an important milestone given their survival benefits, tolerability,
Externí odkaz:
https://doaj.org/article/b5cc9a3fa2f74765826e3fb78f0efa5b